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This study investigated the signaling mechanism underlying the anti-adhesive effect of all-trans retinoic
acid (ATRA) on retinal pigment epithelial ARPE-19 cells. Adhesion kinetics with or without ATRA
treatment were proﬁled by adhesion assay. Surface coating with type IV collagen, ﬁbronectin, laminin,
but not type I collagen, signiﬁcantly enhanced adhesion and spreading of ARPE-19 cells, while ATRA at
subtoxic doses (ranging from 10e7 to 10e6 M) profoundly suppressed the extracellular matrix-enhanced
adhesion ability. Cell attachment on FN activated PI3K/Akt and MAPK cascades, whereas ATRA pre-
treatment blunted the early phosphorylation of Akt and MAPK signaling mediators including p38 MAPK,
JNK1/2, and ERK1/2. Mechanistically, signaling blockade with selective kinase inhibitors demonstrated
that all MAPK pathways were involved in the anti-adhesive effect of ATRA, whereas the PI3K inhibitor
treatment signiﬁcantly potentiated the ATRA-suppressed RPE cell adhesion. Moreover, ATRA treatment
did not affect intracellular F-actin distribution, but remarkably reduced focal adhesion kinase (FAK)
expression and its nuclear localization during ARPE-19 cell attachment. In conclusion, ATRA suppresses
the adhering ability of ARPE-19 cells at least in part through MAPK and FAK pathways. Signaling blockade
with PI3K inhibitor could be regarded as an alternative modality for treating proliferative
vitreoretinopathy.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Proliferative vitreoretinopathy (PVR) is believed to be an
excessive wound healing process and constitutes the leading cause
for failure of retinal detachment surgery (1). In PVR etiology, scar-
like ﬁbrocellular membranes are formed in either vitreous orsearch, E-Da Hospital, I-Shou
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d/4.0/).subretinal space (2). Previous histological observations on surgi-
cally excised membranes demonstrate that retinal pigment
epithelium (RPE) cells are involved in the pathogenesis of PVR (3,4).
The newly formed PVR membranes consist of abundant extracel-
lular matrix (ECM) molecules (5), mainly, collagen type I (Co I),
collagen type IV (Co IV), ﬁbronectin (FN), and laminin (LM). Expo-
sure of RPE cells to proinﬂammatory cytokines leads to not only
increased proliferation and migration (6,7), but also contraction of
the PVR membrane, which, in turn, distorts or detaches the retina
(8). The cell-ECM interactions convey external stimuli to nuclei
through activation of cascades of downstream signaling kinases
including phosphoinositide 3-kinase (PI3K) and Akt, and eventually
leading to actin cytoskeleton remodeling (9,10). In addition, the
activation of PI3K, mitogen activated protein kinase (MAPK) and
focal adhesion kinase (FAK) are reportedly able to modulate RPE
cell behaviors including adhesion, migration, and invasion on ECMnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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Other lines of evidence indicates that activities of stress-activated
kinases, including c-Jun N-terminal kinase (JNK) and extracellular
signal-regulated kinase (ERK), are also involved in the regulation of
RPE cell death (16,17). In fact, recurrent vitreoretinal traction results
in retinal redetachment in more than 25% of the initially successful
PVR surgeries (18,19). Therefore, pharmacological intervention in
the suppression of contractile vitreoretinal response is continuing
to be developed to date.
Retinoic acid, a biologically active metabolite of vitamin A,
pleiotropically regulates cell growth, differentiation, and matrix
formation in various types of tissues and is necessary for
morphogenesis during organ development, including retina
(20,21). Our and other previous studies have shown that all-trans
retinoic acid (ATRA) directly inhibits the proliferation of human
RPE cells isolated from excised PVR membranes (22) and the
intravitreal administration of ATRA effectively prevents experi-
mental PVR induction in animals (23,24). Mechanistically, ATRA
exhibits ECM remodeling effect and suppresses LM-enhanced
contraction of cultured human RPE cells (25). Even though ATRA
has been reported to suppress migration and invasion abilities of
RPE cells (26), not enough is known about the pharmacological
mechanism underlying the anti-adhesion effect of this drug. An
in vitro adhesion assay that involved seeding RPE cell suspension
onto ECM-coated substratumwas used to elucidate the mechanism
of the interaction between cells and ECM molecules as well as the
signal pathways subsequently evoked (27). This study character-
ized the anti-adhesion effect of subtoxic ATRA in ARPE-19 cells,
elucidated the involvement of MAPK signaling mediators, and
further demonstrated the signiﬁcant role of FAK in the adhering
ability of RPE cells.
2. Materials and methods
2.1. Reagents
Dulbecco's modiﬁed Eagle's medium (DMEM) and Ham's F12
1:1 nutrient mixture (DMEM/F12 medium), fetal bovine serum
(FBS), L-glutamine, trypsineEDTA, and antibiotics were from Invi-
trogen/Gibco BRL (Gaithersburg, MD). The ECM coating materials
include bovine serum albumin (BSA, SigmaeAldrich, St. Louis, MO),
Co I (isolated from rat tail tendons as previously described) (25), Co
IV (Southern Biotech, Birmingham, AL), FN (Biomedical Technolo-
gies, Stoughton, MA), and LM nonapeptide (Merck Calbiochem, San
Diego, LA). ATRA and selective kinase inhibitors including Wort-
mannin for PI3K, SB203580 for p38 MAPK, PD98059 for MAPK/ERK
kinase 1 (MEK1), and SP600125 for JNK were purchased from Sig-
maeAldrich. Kinase inhibitors were dissolved in dimethyl sulfoxide
(DMSO) and stocked at 10 mM at 20 C. Antibodies against
phospho-Akt (Ser 473), phospho-ERK1/2 (Thr202/185 and Tyr204/
187), phospho-p38 MAPK (Thr180/Tyr182), phospho-JNK (Thr183/
Tyr185), and those against respective total proteins including FAK
were from Cell Signaling (Beverly, MA). Antibody against b-Actin
was from Merck Millipore (Temecula, CA).
2.2. Cell culture and treatment
A human RPE cell line, ARPE-19, was obtained from American
Type Culture Collection (Manassas, VA) and cultured in a DMEM/
F12 medium supplemented with 10% FBS and regular antibiotics
(Invitrogen/Gibco). For adhesion assay, the trypsinized ARPE-19
cells in suspension were treated with ATRA at the indicated doses
for 1 h and subjected to adhesion assay. For signal pathway survey,
ARPE-19 cell monolayers grown on uncoated dishes were treated
with sub-toxic doses of ATRA for indicated periods.2.3. ECM coating procedures and cell adhesion assay
Culture plates (Corning Inc., Corning, NY) were precoated with
either Co I, Co IV, FN, or LM at 10 mg/cm2 in PBS for 16 h at 4 C as
previously described (27). The plates were further masked with 1%
BSA/PBS for 2 h at 4 C prior to seeding the cells. To examine the
effects of ATRA and kinase inhibitors on RPE cell adhesion, the
adhesion assay was performed by seeding into 96-well plates at
2  105 cells/cm2 as previously described (12,28). For kinetic
characterization of cell adhesion to different ECM-coating surfaces,
the unattached cells were removed at indicated periods after
seeding. To observe the effects of kinase selective inhibitors, the
unattached cells were removed at 20 min post-seeding. The
adherent cells were quantitatively measured by using an MTT-
based cellular viability assay with a 4-h incubation for color for-
mation. Non-seeding wells and those with all untreated cells were
regarded as negative control and 100% attachment, respectively.
2.4. Western blotting
After drug treatment, cells were rinsed with ice-cold PBS and
lyzed in prechilled RIPA buffer with addition of protease and
phosphatase inhibitors. Equal amount (40 mg) of cell protein lysate
in each group was resolved through procedures of SDS-PAGE,
electrotransfering, and immunodetection as previously described
(28). Detection of total and phosphorylated signaling proteins was
performed on separate blots. Band density was measured using
ImageJ image analytical software (National Institutes of Health,
Bethesda, MD). The relative expression levels of target proteins are
shown by the density ratio to b-Actin internal control or to
unphosphorylated total protein in the same sample. All density
results were obtained from three independent experiments and
normalized as percentage or induction folds of negative control
level.
2.5. Immunoﬂuorescent and phalloidin stain
To visualize the subcellular distribution of FAK and F-actin, the
adherent cells grown on glass coverslips were washed with pre-
warmed PBS, ﬁxed in 3.7% formaldehyde solution in PBS for
10 min, and permeabilized with 0.1% Triton X-100 in PBS for 5 min
at room temperature. The cells were then blocked with PBS con-
taining 1% BSA for 30 min, followed by incubation with anti-FAK
antibody (Cell Signaling) at room temperature for 1 h, followed
by Alexa Fluor 594-conjugated anti-rabbit IgG and 5e10 units of
ﬂuorescein-labeled phalloidin (Invitrogen/Molecular Probes,
Eugene, OR) for 30 min at 4 C. After washes with PBS, the nuclei
were counterstained with DAPI, and the slips were sealed with
mountingmedium (DAKO, Glostrup, Denmark) and observed under
a ﬂuorescent microscope.
2.6. Statistical analysis
All results are expressed as themean ± SEM. Datawere analyzed
by using unpaired Student's t test with two-tailed analysis or one-
way ANOVA followed by Tukey's post hoc test. p values < 0.05 are
considered statistically signiﬁcant.
3. Results
3.1. Adhesion kinetics of ARPE-19 cells on different ECM substrata
An adhesion assay was performed to determine the adhesion
kinetics of ARPE-19 cells seeded onto different ECM-coated surfaces
(i.e., BSA, Co I, Co IV, FN, and LM). The attachment kinetics were
Y.-C. Chang et al. / Journal of Pharmacological Sciences 132 (2016) 262e270264observed at different time points within 1 h after cell seeding and
adherent cells were quantiﬁed by an MTT-based cellular viability
assay. Similar to the results of our previous study using other RPE
cell line R-50 cells (27), Co I-coated substratum did not inﬂuence
adhesion of ARPE-19 cells, whereas BSA coating prominently
diminished the interaction between the cells and the plastic surface
of culture plates at the initial stage of adhesion. Intriguingly, FN, LM,
and Co IV-coated surfaces signiﬁcantly increased the adhering
ability of cells at 10 min after seeding and thereafter (Fig. 1A). In
parallel, microscopic observation on cell morphology at 20 min
after seeding revealed that the cells seeded on FN, LM, and Co IV-
coated substrata exhibited better cell adhesion and spread with a
more ﬂattened morphology compared to other ECM coatings
(Fig. 1B).3.2. Suppressive effect of ATRA on adhesion kinetics of ARPE-19 cells
Consistent with a recent study on ARPE-19 cells (29), our pilot
observation on cell growth rate clearly indicated that ATRA at doses
equal to or lower than 10e6 M exerted no prominent cytostatic
effect on ARPE-19 cells (Fig. S1). To examine whether ATRA treat-
ment affects adhesion kinetics of RPE cells onto different ECM
substrata, ARPE-19 cells in suspension were treated with ATRA for
1 h and then subjected to the adhesion assay by seeding treatedFig. 1. Adhesion kinetics and morphology of cultured ARPE-19 cells seeded on
different ECM. (A) Adhesion assay was performed by seeding human ARPE-19 cells on
24-well plates precoated with either type I collagen (Co I), Co IV, FN, LM, or BSA. The
percentage of cell attachment was shown as mean ± SEM of three independent ex-
periments. NC, non-coating control. (B) Morphology of adherent ARPE-19 cells at
20 min after seeding. Bar ¼ 50 mm.cells onto various ECM-coated surfaces. Adhesion kinetic proﬁles in
a time-frame of 60 min showed that a short exposure to ATRA
effectively suppressed the adhering ability of ARPE-19 cells. Sig-
niﬁcant suppression of ATRA treatment on cell adhesion could be
seen with ATRA doses ranging from 10e7 to 10e6 M when the
treated cells were seeded onto not only uncoated-(Fig. 2A) and
BSA-coated wells (Fig. 2B) but also ECM-coated surfaces, including
Co I (Fig. 2C), Co IV (Fig. 2D), FN (Fig. 2E), and LM (Fig. 2F). In
addition, ATRA at 10e8 M also exerted suppressive effect on the cell
seeded onto LM (Fig. 2F). Typical pharmacodynamic suppression by
ATRA under these ECM microenvironments was inferred from the
data at 30 min post-seeding, which clearly indicated the ATRA
doses ranging from 10e7 to 10e6 M were optimal for the effective
suppression of adhesion of RPE cells to ECM (Fig. 3).
3.3. Kinetic proﬁles of ATRA-induced signaling in adherent ARPE-19
cells
To further delineate the effects of ATRA exposure on signaling
activity in both MAPK and PI3K/Akt pathways, adherent ARPE-19
cells were treated with 10e6 M ATRA and the lysates collected
during a 120-min time frame were subjected to western blotting
detection of the total and phosphorylated contents of signaling
mediators (Fig. 4A). Subsequent densitometric analysis clearly
pointed out that exposure to ATRA prominently increased the
phosphorylation of Akt (Fig. 4B), p38 MAPK (Fig. 4C), and JNK1/2
(Fig. 4D), but only induced a transient rise of ERK1/2 phosphory-
lation and a quick reduction to lower than its constitutive level
(Fig. 4E).
3.4. ATRA reduced PI3K/Akt and MAPK signaling activities in
adhering and spreading ARPE-19 cells
Since PI3K/Akt and MAPK signaling activities have been impli-
cated in the regulation of RPE cell adhesion (12,15), we next
observed the phosphorylation kinetics of Akt, JNK1/2, p38 MAPK,
and ERK1/2 during the adhering and spreading processes of ARPE-
19 cells seeded onto FN-coated surfaces (Fig. 5A). Western blotting
and densitometry analyses clearly showed that there were mod-
erate elevations in the phosphorylated levels of Akt and MAPK
mediators during adhering and spreading processes. Although
ATRA pretreatment increased phosphorylation levels of Akt and
p38 MAPK in the suspended cells, it signiﬁcantly promoted the
time-dependent decrease in Akt phosphorylation (Fig. 5B), blunted
the adhesion-induced phosphorylation of p38 MAPK (Fig. 5C) and
ERK1/2 (Fig. 5E), but remarkably potentiated the induced JNK1/2
hyperphosphorylation (Fig. 5D) in adhering ARPE-19 cells. These
observatory data were obtained in the course of cell attachment
within 3 h after seeding in comparison with the corresponding
phosphorylation levels in solvent controls.
3.5. Involvement of MAPK signaling in anti-adhesion of ATRA
To further determine the involvement of ATRA-triggered
signaling in its anti-adhesion effect, suspended ARPE-19 cells
received 1 h of simultaneous treatment with ATRA (10e6 M) and
10 mM of kinase-selective inhibitors and the adhesion assay was
performed after 20 min of attachment. The results indicated that
pretreatment with MAPK inhibitors including SB203580,
SP600125, and PD98059 for blocking the upstream kinases
responsible for p38 MAPK, JNK1/2, and ERK1/2 phosphorylation
respectively, did not affect the ATRA-induced anti-adhesion effects
in non-coating control groups (Fig. 6A). On the contrary, all MAPK
inhibitors signiﬁcantly mitigated the anti-adhesion effect of ATRA
in the ARPE-19 cell seeded onto the dishes coated with BSA
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Fig. 2. Effect of all-trans retinoic acid (ATRA) on the adhesion kinetics of ARPE-19 cells grown on different ECM. ARPE-19 cells in suspension were treated with ATRA at the indicated
doses for 30 min and subjected to adhesion assay by seeding cells onto either uncoated dishes (A) or those precoated with BSA (B), Co I (C), Co IV (D), FN (E), or LM (F). A negative
control (NC) without ATRA treatment and a solvent control with 0.1% DMSO were tested in parallel. Measured data of all seeded cells without being washed away was considered as
100%. Data are expressed as mean ± SEM of three independent experiments.
Y.-C. Chang et al. / Journal of Pharmacological Sciences 132 (2016) 262e270 265(Fig. 6B), Co I (Fig. 6C), Co IV (Fig. 6D), FN (Fig. 6E), and LM (Fig. 6F).
Blockage of PI3K/Akt signaling by wortmannin signiﬁcantly
aggravated the anti-adhesion effect of ATRA on ARPE-19 cells, with
the exception of cells seeded onto Co IV and LM-coated surfaces.
However, cell viability assay data revealed that, although long-term
PI3K inhibition indeed reduced cell viability (Fig. S2A), a short-
period exposure to PI3K inhibitor at 10 mM did not affect the
overall RPE cell viability (Fig. S2B), excluding the cell death-
inducing effect of PI3K inhibition in nascent adhesions.
3.6. Effects of ATRA on FAK expression and its localization during
adhesion
Our group as well as others have earlier demonstrated that ATRA
suppresses the de novo synthesis of integrin b3 (25) and inhibits
TGF-b-induced collagen gel contraction of human tendon ﬁbro-
blasts by attenuating TGF-b-induced FAK phosphorylation and
stress ﬁber formation (30). We, therefore, examined whether ATRA
directly affects FAK expression and adhesion-related cytoskeleton
redistribution in ARPE-19 cells during the adhering process.
Western blotting indicated that prior exposure to 10e6 M ATRA for
30 min signiﬁcantly decreased FAK expression levels in the
adhering ARPE-19 cells (Fig. 7A, B). Immunoﬂuorescent micro-
scopic observation after phalloidin-FITC staining revealed that
ATRA did not affect intracellular distribution of F-actin cytoskel-
eton, but the spotty and membranous FAK localization was prom-
inently reduced in the adherent ARPE-19 cells pretreated with
ATRA (Fig. 7C). The cell morphology of ATRA-treated cells showed
smaller cell size, implicating that ATRA might suppress cell
spreading during nascent adhesion. Intriguingly, nuclear FAK
localization was also seen in the adherent ARPE-19 cells at 2 h and
6 h after seeding, while the number of FAK-positive cells withnuclear localizationwas remarkably reduced by ATRA pretreatment
(Fig. 7D). These ﬁndings strongly suggest that ATRA affects the cell-
to-ECM adhesion process of RPE cells through modulating the
expression of FAK and its subcellular localization.4. Discussion
The suppressive effect of ATRA on proliferation, contraction and
migration of RPE cells has been previously identiﬁed by our and
other groups (22,25,26). The present study sought to elucidate the
mechanism through which ATRA affects the adhesion ability of
ARPE-19 cells on different ECM substrates and further evaluated
the molecular intervention of ATRA on adhesion-induced signaling
activities. This study clearly delineated the attachment-induced
phosphorylation proﬁles of signaling mediators immediately after
ARPE-19 cells were seeded onto the FN-coated substratum. We
noted that the hyperphosphorylation of p38 MAPK, JNK1/2, and
ERK1/2 in the suspended RPE cells was dramatically up-regulated
upon adherence to the FN-coated surfaces (Fig. 5). The kinetic
proﬁles of signaling mediators strongly suggest that the environ-
ment enriched with FN or other pathogenic ECM molecules is
responsible for the enhanced adhesiveness of activated RPE cells. In
the pathogenesis of PVR, the increased FN levels in subretinal and
vitreous ﬂuids have long been implicated in the initiation of epi-
retinal membrane formation (31), enhanced expression of TGF-b2-
induced a-smooth muscle actin during RPE cell transdifferentiation
(32), and increased motility of RPE cells (33). The present study
showed, for the ﬁrst time, that exposure to either ATRA, PI3K in-
hibitor, or both may exert anti-adhesion effect on ARPE-19 cells,
corroborating the underlying pharmacological mechanism in the
PVR treatment.
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Fig. 3. Anti-adhesive effect of all-trans retinoic acid (ATRA) on ARPE-19 cells. Suspended ARPE-19 cells were pretreated with ATRA at the doses indicated for 30 min and subjected
to adhesion assay by seeding cells on the non-coated dishes (A) or those precoated with BSA (B), Co I (C), Co IV (D), FN (E), or LM (F). A negative control (NC) without ATRA treatment
and a solvent control with 0.1% DMSO were done in parallel. Floating cells were removed at 30 min after seeding. Measured data of all seeded cells without being washed away was
considered as 100%. Data are expressed as mean ± SEM of three independent experiments. *p < 0.05 vs. DMSO solvent control group.
Fig. 4. Kinetic proﬁles of all-trans retinoic acid (ATRA)-induced phosphorylation of signaling mediators in adherent ARPE-19 cells. ARPE-19 cells grown on non-coated dishes were
treated with ATRA at 10e6 M for indicated time and protein lysates were subjected to western blot detection (A). Band density analysis was performed to quantify the phos-
phorylation of signaling mediators including Akt (B), p38 MAPK (C), JNK1/2 (D), and ERK1/2 (E). Induction data were normalized relative to untreated control. Data are repre-
sentative images from three independent experiments.
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Fig. 5. All-trans retinoic acid (ATRA) pretreatment reduced PI3K/Akt and MAPK signaling activities in adhering and spreading ARPE-19 cells. (A) ARPE-19 cells in suspension were
treated with 10e6 M ATRA for 30 min and seeded onto ﬁbronectin-coated dishes. The protein lysates were collected at the indicated time points and subjected to western blotting
detection for total and phosphorylated contents of kinase substrates. Band density analysis was performed to quantify the phosphorylation of kinases including Akt (B), p38 MAPK
(C), JNK1/2 (D), and ERK1/2 (E). Induction data were normalized relative to untreated control. Data are expressed as mean ± SEM of three independent experiments. *p < 0.05 vs.
DMSO-treated group.
Fig. 6. Involvement of all-trans retinoic acid (ATRA)-triggered signaling pathway in its anti-adhesion effect. After trypsinization, ARPE-19 cells in suspension received 1 h of
simultaneous treatment with ATRA (10e6 M) and 10 mM of kinase inhibitors, including SB203580 (SB), SP600125 (SP), PD98059 (PD), wortmannin (WM), or equivalent DMSO as a
solvent control. Cells were then seeded onto non-coated surface (A) or surfaces precoated with either BSA (B), Co I (C), Co IV (D), FN (E), or LM (F). Adhesion assay was performed
after 20 min of attachment. A control without cell removal was considered as 100%. Data are expressed as mean ± SEM of adhesion suppression of three independent experiments.
*p < 0.05 vs. negative control (NC) and #p < 0.05 vs. DMSO-treated group. NS, not signiﬁcant vs. solvent control.
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Fig. 7. All-trans retinoic acid (ATRA) suppresses expression of focal adhesion kinase (FAK) and modulates its subcellular distribution in adhering ARPE-19 cells. (A) The suspended
cells treated with either ATRA at 10e6 M or equivalent DMSO for 30 min were seeded onto ﬁbronectin (FN)-coated dishes. At the indicated time after seeding, protein lysates were
subjected to western blot detection of FAK. (B) Densitometry of FAK expression in adhering cells. Density data are expressed as mean ± SEM of three independent experiments.
*p < 0.05 vs. corresponding DMSO-treated groups. (C) Changes of cellular FAK localization in adhering ARPE-19 cells with ATRA treatment. The cells were pretreated with ATRA
(10e6 M) or equivalent DMSO for 30 min, and then seeded onto FN-coated coverslips. At 2 h after seeding, the ﬁxed cells were immunoﬂuorescently stained with anti-FAK antibody
(signals in red), cytoskeletal F-actin was visualized with phalloidin-FITC (signals in green), and nuclei were counterstained with DAPI (signals in blue). Arrows and arrowheads
indicate membranous and nuclear FAK locations, respectively. Bars ¼ 20 mm. (D) Nuclear localization of FAK was quantiﬁed in the cells with or without ATRA pretreatment. Data are
expressed as mean ± SEM. *p < 0.05 vs. corresponding negative control (NC).
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demonstrated that ATRA exposure activated multiple signaling
pathways, including MAPK and PI3K/Akt cascades. The ATRA-
activated p38 MAP kinase is known to promote apoptosis and dif-
ferentiation in photoreceptors, while its activating role in the ERK1/
2 MAPK cascade is not only implicated in chick retina (21), but also
in the TNF-a-enhanced RPE cell attachment, spreading and
migration on FN and Co I matrices (12). Besides, PI3K/Akt signaling
cascade is reportedly involved in the RPE cell-mediated collagen gel
contraction (11). In this study, we demonstrated that ATRA pre-
treatment signiﬁcantly decreased the adhering ability of ARPE-
19 cell onto different ECM coatings (Fig. 2), while inhibition of
MAPK activities ameliorated the ATRA-suppressed cell adhesion
(Fig. 6), strongly suggesting the involvement of multiple MAPK
activities in the ATRA-interrupted adhering ability of ARPE-19 cells.
Our previous study using the other RPE cell line, clone R-50,
demonstrated the critical role of PI3K/Akt pathway in regulation of
RPE cell adhesion (27). Besides, Akt activation was reported to
confer survival signal through up-regulating anti-apoptotic Bcl-2
expression in RPE cells (15). This study consistently noted that
PI3K/Akt signaling inhibition signiﬁcantly potentiated the ATRA-
exhibited anti-adhesion effect in ARPE-19 cells. These results,
taken together with the previous report showing the involvement
of PI3K/Akt signal pathway in regulation of RPE cell proliferation
(34), suggest that PI3K inhibitors could be potential therapeutic
agents for the PVR treatment. However, we still have to emphasize
the difference between in vitro and in vivo scenarios and address
the risks involved in kinase intervention, such as induction of RPE
cell apoptosis and early retinal degeneration. Therefore, selectivekinase inhibitors need to be evaluated extensively for the treatment
of PVR.
In the context of PVR pathogenesis, retinal contraction involves
the increase of both cell-to-cell and cell-to-ECM tractional force;
the latter is brought about by up-regulation of integrins, activation
of FAK, and subsequent mobilization and remodeling of intracel-
lular cytoskeletons (13). In line with the pathophysiological sig-
niﬁcance in tumor cells (35), the regulatory roles of integrin/FAK
signal axis have been known tomodulate proliferation, contraction,
migration, and invasion of RPE cells (13,14). Ex vivo RPE culture of
clinical specimens supports that the elevated FAK activity is closely
linked to the PVR severity. The increased expression of integrin and
its co-localization with phosphorylated FAK in cultured RPE cells
has also been claimed to improve resurfacing of aged submacular
human Bruch's membranes (36). As a consequence, integrin/FAK-
mediated signaling may confer protective effect on RPE (37), in-
crease contractility of ARPE-19 cells in collagen gels (38), and
mediate RPE phagocytosis (39). Conversely, the integrin/FAK axis
blockade prominently decreases the activation and transformation
of cultured RPE cells (40,41) as well as the experimental PVR
development (42). In the experiments designed to elucidate the
regulatory role of FAK activation in adhering RPE cells, this study
demonstrated that the FAK expression remained constant during
the adhering processes of ARPE-19 cells, while prior exposure to
ATRA signiﬁcantly reduced the constitutive level of FAK as well as
its subcellular distribution (Fig. 7). Akt, MAPK and FAK signaling
activations have been reported to be involved in the ﬁbrogenic
growth factor and periostin-induced RPE cell activation (42,43). We
clearly showed in the present study that ATRA may play a
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through interrupting these signaling cascades. In particular, the
ATRA-induced p38 activation is reported to promote apoptosis and
differentiation of photoreceptor neuron cells (44). On the other
hand, the modulatory role of integrin/FAK signaling axis has been
previously suggested to participate in the formation of choroidal
neovascularization through up-regulating VEGF expression in RPE
cells (45,46). The ATRA-driven suppression in the FAK signaling
activity implies the possibility that it may decrease VEGF produc-
tion by RPE cells, thereby suppressing choroidal neovascularization.
However, intraperitoneal injection of ATRA is contradictorily found
to inhibit VEGF expression and retinal neovascularization in
experimental retinopathy of prematurity (47), while the effects of
ATRA on VEGF up-regulation and stabilization is recently claimed to
support retinal vascular development (48). This controversy awaits
resolution.
In addition to its suppressive effect on FAK activity, ATRA
treatment was also noted to signiﬁcantly reduce nuclear abundance
of FAK proteins in adhering ARPE-19 cells. As an integrin co-
stimulatory signal, FAK protein is known to shuttle from focal ad-
hesions to the nucleus to directly convey extracellular signals (49).
More intriguingly, the nuclear FAK is now regarded as a co-
transcriptional regulator that alters transcription of pro-
inﬂammatory adhesion molecules and chemkines, thereby
enhancing cell proliferation and reducing inﬂammatory response
through p53 and GATA4 ubiquitination and degradation (49e51).
Due to this reason, the ATRA-reduced nuclear FAK levels in
adhering RPE cells may additionally contribute to its immunosup-
pressive function, because a plethora of chemokines have been
recently identiﬁed to be produced by RPE cells (52). Nuclear
translocation of FAK is suggested to be prominent under kinase-
inhibited conditions such as in de-adhesion and pharmacological
FAK inhibition (49). Our ﬁndings showed that nuclear staining
pattern of FAK was prominent in most of the adhering ARPE-
19 cells, but less in ATRA-treated cells (Fig. 7). These ﬁndings
collectively support that FAK is a promising therapeutic target for
PVR. Intriguingly, ATRA is controversially found to induce nuclear
FAK translocation but reduce breast cancer cell adhesion (53). To
solve this question, additional experimentation is needed to detail
the molecular mechanisms of FAK-mediated signaling in the
pathogenesis of PVR.
In conclusion, ATRA suppresses ARPE-19 cell adhesion on ECM
substratum in addition to its anti-mitogenic effect. Although ECM
enhances cell adhesion and activates MAPK and FAK signaling, the
pharmacological mechanisms underlying the ATRA-suppressed
RPE cell adhesion may, at least in part, involve multiple MAPK
signaling pathways as well as FAK down-regulation and its sub-
cellular re-localization. Signaling blockade with PI3K inhibitor
could be regarded as an alternative modality for PVR treatment.
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